Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal Saunders said the deal gives its aesthetic pharmaceuticals business another pillar alongside Botox for facial wrinkles, its plastic surgery products and regenerative medicines. ... The division grew 40% to $1.62bn last year, with the sales increase

Allergan buys regenerative medicine firm LifeCell for $2.9bn

Allergan buys regenerative medicine firm LifeCell for $2.9bn Those are headed by blockbuster wrinkle treatment Botox but also include Kybella - bought along with Kythera last year for $2.1bn - for reducing double chins and dermal filler Juvederm.

Shire launches dry eye drug Xiidra in US

Shire launches dry eye drug Xiidra in US Allergan made around $1.3bn in sales from Restasis last year, which made it the company's second-biggest product after wrinkle treatment Botox.

Explosive evolution

Explosive evolution governments. We see this when we compare, for example, generic Paracetamol with Allergan's Botox and Bayer's Xarelto.

Size matters?

Size matters? There is also Allergan's traditional strength in aesthetics, most notably Botox (a pharma product whose place in the popular imagination is perhaps the closest to Pfizer's own Viagra), though

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics